Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 14, 2024. (Total: 232476Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Lung Neoplasms and IGF1R[original query]
Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 May 28 (13): 2174-80.
Dziadziuszko Rafal, Merrick Daniel T, Witta Samir E, Mendoza Adelita D, Szostakiewicz Barbara, Szymanowska Amelia, Rzyman Witold, Dziadziuszko Katarzyna, Jassem Jacek, Bunn Paul A, Varella-Garcia Marileila, Hirsch Fred
Mutational analysis of the insulin-like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients.
Molecular and clinical oncology 2015 Sep 3 (5): 1073-1079.
Gately Kathy, Forde Lydia, Gray Stephen, Morris Derek, Corvin Aidan, Tewari Prerna, O'Byrne Kenne
The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation.
International journal of molecular sciences 2016 May 17 (5): .
Liu Tu-Chen, Hsieh Ming-Ju, Liu Ming-Che, Chiang Whei-Ling, Tsao Thomas Chang-Yao, Yang Shun-
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
PloS one 2017 12 (7): e0181527.
Al-Saad Samer, Richardsen Elin, Kilvaer Thomas K, Donnem Tom, Andersen Sigve, Khanehkenari Mehrdad, Bremnes Roy M, Busund Lill-To
Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation.
Molecular cancer research : MCR 2017 07 15 (7): 915-928.
Yamaoka Toshimitsu, Ohmori Tohru, Ohba Motoi, Arata Satoru, Murata Yasunori, Kusumoto Sojiro, Ando Koichi, Ishida Hiroo, Ohnishi Tsukasa, Sasaki Yasutsu
Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations.
Cancer communications (London, England) 2019 3 39 (1): 7.
Wang Fang, Diao Xia-Yao, Zhang Xiao, Shao Qiong, Feng Yan-Fen, An Xin, Wang Hai-Y
Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.
Thoracic cancer 2019 11 11 (1): 140-149.
Hayakawa Daisuke, Takahashi Fumiyuki, Mitsuishi Yoichiro, Tajima Ken, Hidayat Moulid, Winardi Wira, Ihara Hiroaki, Kanamori Koichiro, Matsumoto Naohisa, Asao Tetsuhiko, Ko Ryo, Shukuya Takehito, Takamochi Kazuya, Hayashi Takuo, Suehara Yoshiyuki, Takeda Nakamura Ikuko, Ueno Toshihide, Kohsaka Shinji, Mano Hiroyuki, Takahashi Kazuhi
Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma.
Frontiers in oncology 2020 10 607130.
Qian Jie, Chen Rongrong, Zhao Ruiying, Han Yuchen, Yu Yongfe
Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing.
Journal of thoracic disease 2021 Aug 13 (8): 5007-5015.
Zhang Fan, Wang Junyan, Ma Minting, Xu Yu, Lu Xiangjun, Wei Su
TOP